Carbapenemase-mediated resistance in Acinetobacter baumannii clinical isolates: molecular epidemiology and antimicrobial potential of chitosan nanoparticles.

Abdullah F, Azmy AF, Eldin ZE, Ahmed ME, Molham F

Open source

DOI
10.1186/s12866-025-04706-w
Published
2026 Feb 2
Container
BMC microbiology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12866-025-04706-w,
  title = {Carbapenemase-mediated resistance in Acinetobacter baumannii clinical isolates: molecular epidemiology and antimicrobial potential of chitosan nanoparticles.},
  author = {Abdullah F and Azmy AF and Eldin ZE and Ahmed ME and Molham F},
  year = {2026},
  journal = {BMC microbiology},
  doi = {10.1186/s12866-025-04706-w},
  url = {https://doi.org/10.1186/s12866-025-04706-w}
}

RIS

TY  - JOUR
TI  - Carbapenemase-mediated resistance in Acinetobacter baumannii clinical isolates: molecular epidemiology and antimicrobial potential of chitosan nanoparticles.
AU  - Abdullah F
AU  - Azmy AF
AU  - Eldin ZE
AU  - Ahmed ME
AU  - Molham F
PY  - 2026
JO  - BMC microbiology
DO  - 10.1186/s12866-025-04706-w
UR  - https://doi.org/10.1186/s12866-025-04706-w
ER  - 

APA

F, A., AF, A., ZE, E., ME, A., & F, M. (2026). Carbapenemase-mediated resistance in Acinetobacter baumannii clinical isolates: molecular epidemiology and antimicrobial potential of chitosan nanoparticles.. BMC microbiology. https://doi.org/10.1186/s12866-025-04706-w

Source records